3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
19
Lung Neoplasms
11
Prostatic Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Prostatic Neoplasms, Castration-Resistant
4
Neoplasm Metastasis
4
Stomach Neoplasms
3
Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Transitional Cell
3
Carcinoma
3
Breast Neoplasms
3
Adenocarcinoma
3
Urinary Bladder Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Melanoma
2
Lymphoid Interstitial Pneumonia
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Non-small Cell Lung Cancer Metastatic
1
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
1
Neoplasms by Site
1
Interventions
Carboplatin
3
fludarabine
2
Pemetrexed
2
Nivolumab
2
Ipilimumab
2
Cyclophosphamide
2
Cisplatin
2
pembrolizumab
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
Radiotherapy, Intensity-Modulated
1
Platinum
1
Fluorodeoxyglucose F18
1
Cerebral Decortication
1
Blood Component Removal
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
Docetaxel
×
30 days
×
Clear all
No trials found.